Mymetics
Business Services · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Rte De La Corniche 4, Epalinges, Vaud, 1...Phone Number
+41 216534535Website
www.mymetics.comRevenue
<$5 MillionStock Symbol
MYMXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Mymetics
Mymetics Corporation (OTCQB:MYMX) is a Swiss based biotechnology company, with a research lab in the Netherlands, focused on the development of next-generation preventative vaccines for infectious and life disabling diseases. It currently has several vaccines in its pipeline: HIV-1/AIDS, intra-nasal Influenza, malaria, Chikungunya and the RSV vaccine in addition to several ongoing collaborative projects in the field of allergy and oncology Immunotherapy. Mymetics' core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigen and adjuvants.Explore more
Mymetics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mymetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Mymetics recently announced quarterly report
Product Launch: Get notified when Mymetics launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Mymetics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Mymetics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Mymetics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Mymetics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Mymetics
Check out if Mymetics is spiking on competitors!
Recommended Actions
Find VP level buyers at Mymetics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Mymetics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mymetics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mymetics.
Mymetics Tech Stack
A closer look at the technologies used by Mymetics
Mymetics News & Media
Mymetics receives HIV Vaccine Funding from the NIH
EPALINGES, Switzerland, April 29, 2019 /PRNewswire/ -- Mymetics Corporation (OTCQB: MYMX), a pioneer and leader in the research and development of virosome-based vaccines against life threatening and life disabling diseases, announced today that the National Institutes of Health (NIH) has ...Mymetics Virosomes Successful in Allergy Proof-of-Concept Study
Success criteria met: Bet v 1 COP-virosomes showed no IgE induction, favorable TH1 response and were well tolerated in mice study Anergis has time limited exclusive option to license Mymetics' virosome technology in the field of allergies EPALINGES, SWITZERLAND / ACCESSWIRE / December 13, 2018 / Mymetics Corporation (OTCQB: MYMX), a pioneer and leader in the research and development of virosome-based vaccines against life threatening and life disabling diseases, announced today that the pre-clinMymetics Presents New Data Regarding Cold Chain Independent Virosome Based Vaccines
EPALINGES, SWITZERLAND / ACCESSWIRE / November 14, 2018 / Mymetics Corporation (OTCQB: MYMX), a pioneer and leader in the research and development of virosome-based vaccines against life-threatening and life disabling diseases, announces that new data is presented today by Mymetics at the annual Mucosal Vaccines, Adjuvants and Delivery meeting in Lausanne, Switzerland. Since 2015, Mymetics has been leading a consortium to develop thermostable and cold-chain independent virosome-based vaccines. TNew Mymetics data to be presented by LMIV at American Society of Tropical Medicine and Hygiene
EPALINGES, Switzerland, Oct. 30, 2018 /PRNewswire/ -- Mymetics Corporation (OTCQB: MYMX), a pioneer and leader in the research and development of virosome-based vaccines against life threatening and life disabling diseases announces that new data will be presented at the 67th American...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mymetics
Sign Up For FreeTo access detailed company insights
Mymetics Corporation (OTCQB:MYMX) is a Swiss based biotechnology company, with a research lab in the Netherlands, focused on the development of next-generation preventative vaccines for infectious and life disabling diseases. It currently has several vaccines in its pipeline: HIV-1/AIDS, intra-nasal Influenza, malaria, Chikungunya and the RSV vacci... Read More
